| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rubin Jami is a Director at RLAY. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $1.3M at current prices.
Rubin Jami's largest disclosed position is in RLAY as Director, worth about $1.3M. Net of sales, the recent Form 4 record there shows accumulation of 25,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2020 | RLAY Relay Therapeutics, Inc. | Director | Buy | 25,000 | $20.00 | $500,000.00 | New |